REPLIMUNE GROUP INC's ticker is REPL and the CUSIP is 76029N106. A total of 107 filers reported holding REPLIMUNE GROUP INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $784,322 | +248.2% | 45,840 | +372.6% | 0.00% | +200.0% |
| Q2 2023 | $225,234 | +1004.1% | 9,700 | +1193.3% | 0.00% | – |
| Q4 2022 | $20,400 | -61.5% | 750 | -58.2% | 0.00% | – |
| Q3 2021 | $53,000 | -75.8% | 1,794 | -68.5% | 0.00% | – |
| Q2 2021 | $219,000 | +30.4% | 5,694 | +3.5% | 0.00% | – |
| Q1 2021 | $168,000 | – | 5,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 3,050,187 | $53,866,302 | 35.13% |
| Atlas Venture Life Science Advisors, LLC | 2,098,300 | $37,055,978 | 5.02% |
| Redmile Group, LLC | 3,811,988 | $67,319,708 | 2.92% |
| Nan Fung Group Holdings Ltd | 189,339 | $3,343,727 | 2.28% |
| Altium Capital Management LP | 148,000 | $2,613,680 | 1.45% |
| Integral Health Asset Management, LLC | 395,000 | $6,975,700 | 1.40% |
| BVF INC/IL | 2,143,036 | $37,846,016 | 1.38% |
| Resolute Capital Asset Partners LLC | 82,500 | $1,457 | 1.06% |
| SECTORAL ASSET MANAGEMENT INC | 262,200 | $4,630,452 | 0.89% |
| Frazier Life Sciences Management, L.P. | 686,762 | $12,128,217 | 0.88% |